The leucocyte adhesion molecule Lselectin (CD62L) is rapidly cleaved offproteolytically after cell activation, generating soluble L-selectin (sCD62L) molecules. sCD62L concentrations were determined in 185 cerebrospinal fluid (CSF) samples obtained from children aged 1 month to 17 years. In 36 CSF samples of children with meningoencephalitis, sCD62L was significantly higher (median 209 fmol/ml) than in samples of children with other febrile diseases (n=67, median 50 finoi/ml) or non-febrile disorders (n=82, median 44 finol/ml). There was a positive correlation between CSF protein and CSF sCD62L (r,=0.68), suggesting that a disturbed blood-brain barrier contributes to raised sCD62L concentrations in the CSF. However, the CSF sCD62L/protein ratio of children with meningoencephalitis was significantly higher than in children with other febrile diseases or non-febrile disorders, indicating that sCD62L concentrations in children with meningoencephalitis were higher than expected from plasma leakage alone. It is concluded that both an impaired blood-brain barrier and the generation of sCD62L by infiltrating leucocytes contribute to raised CSF sCD62L concentrations in children with meningoencephalitis. (Arch Dis Child 1996; 74: 288-292) Keywords: cerebrospinal fluid, soluble L-selectin, meningoencephalitis. 
The leucocyte surface adhesion glycoprotein Lselectin (CD62L) mediates reversible attachment of flowing leucocytes to altered or specialised endothelium' and endothelium bound leucocytes2 which precedes leucocyte extravasation. Following cell activation, CD62L is rapidly cleaved off,34 and shed soluble Lselectin (sCD62L) appears in the surrounding fluid as 62 kDa and 75-100 kDa fragments with preserved ligand binding capacity.5 It has been reported that plasma or serum sCD62L concentrations were increased in patients with insulin dependent diabetes mellitus,6 acquired immunodeficiency syndrome,7 and a proportion of patients with acute leukaemia,8 while decreased sCD62L was found in premature newborn infants9 10 and neutropenic patients after bone marrow transplantation.11 Low concentrations of sCD62L have also been detected in cerebrospinal fluid (CSF), with marked elevations in patients with meningeal leukaemia.12 The aim of this study was to determine whether sCD62L concentrations were increased in the CSF in children with acute inflammatory central nervous system (CNS) diseases.
Material PATIENTS sCD62L concentrations were measured in 185 CSF leftovers of samples submitted to the routine paediatric laboratory between January 1993 and August 1994. The analysis was restricted to children between 1 month (corrected for prematurity) and 17 Although a positive correlation was found )sitive and between CSF nucleated cell counts and CSF and 0-96, sCD62L levels, the leucocytes suspended in 2Liprotein the CSF at the time of lumbar puncture can be ated with a expected to contribute only a minor fraction of 0 90, and CSF sCD62L. Assuming there are approxiies of 0-62 mately 30 000 CD62L molecules per unstimuunder the lated leucocyte,21 even complete shedding of nd 0-83 for CD62L within the CSF compartment would result in no more than 5X 0-5 fmol sCD62L )62L con-per cell. The upper limit of the proportion of d a similar sCD62L shed from leucocytes in the CSF g between sample can be calculated to be 3-8% (10-90th litis, while centile range 1-10/o493%). As a highly helpful in glycated glycoprotein, sCD62L is easily ietiologies. soluble in aqueous solutions; thus both leucoLs 0-88 for cytes suspended in CSF and an unknown or the CSF number of leucocytes attached to neuronal and sCD62L glial structures may contribute to CSF nucleated sCD62L. Since it is well documented that 316 fmol shedding of sCD62L from leucocytes is largely 
reflects the number of infiltrating leucocytes as well as their state of activation. In addition, CSF sCD62L concentrations may also be influenced by the duration of the inflammatory process. Owing to the lack of data regarding the half life of sCD62L in CSF (at 37°C), accumulation of sCD62L produced by repetitive waves of infiltrating leukocytes in the CSF over time remains a matter of speculation.
The predominant infiltrating leucocytes in acute meningoencephalitis of bacterial and viral origin, neutrophils and lymphocytes respectively, require different signals for downregulation of CD62L surface expression in vitro. Neutrophils shed their surface expressed CD62L molecules within minutes after contact with soluble mediators of inflammation, such as interleukin-I or tumour necrosis factor-a3 which have been shown to be present in CSF during acute bacterial meningoencephalitis. '7 2223 In contrast, lymphocyte CD62L shedding does not occur in response to the above mentioned cytokines or interferon--y, appears to require prolonged antigenic stimulation, and may take several hours to be complete.24 Thus both the distinct signalling cascades involved and the disparate number of infiltrating leucocytes may contribute to the difference in CSF sCD62L concentrations observed in bacterial and viral meningoencephalitis.
The results in children with febrile diseases without CNS inflammation may be used to define a reference value of sCD62L concentrations in the CSF. However, none of the assays currently employed to quantitate sCD62L in biological fluids appears to have been sufficiently standardised by recombinant or highly purified natural sCD62L, and there is some discrepancy as to the normal sCD62L serum range.5 7-10 Some investigators prefer to express their data as relative units.6 11 While conclusions drawn from measurements with the same assay system are not affected by this problem, definitive reference values will have to await comparative testing of recombinant or highly purified natural sCD62L. In addition, sCD62L found in human body fluids is actually composed ofvarious molecular species with molecular weights ranging from 62 to 100 kDa,5 most probably because of variable glycation of the protein core. Since the monoclonal antibodies used in several ELISA systems do not discriminate between the various sCD62L isoforms generated by differential glycation, the common practice of conversion of ELISA generated data from fnol/ml to ng/ml is inaccurate (100 fmol/ml may correspond to anything between 6-2 and 10 ng/ml).
The area under the ROC curves for CSF sCD62L and the CSF sCD62L/protein ratio shows that both variables are fairly accurate in distinguishing children with and without meningoencephalitis. In addition, CSF sCD62L levels but not the CSF sGD62IJpro-tein ratio discriminates between bacterial and viral meningitis. However, the sandwich ELISA used in this study takes four to five Seven children had their first symptoms before the age of 10 and 21 between ages 10 and 15 years. Two were aged 1 and 2 years but the rest were 6 or over. The features of the disease were similar to those seen in adults but 11 children had a systemic illness at the onset which is uncommon in adults. Presenting features were: limb, bulbar or facial weakness (15) , visual blurring (10), sensory loss (9), ataxia (3), bladder dysfunction (3), vertigo (2), and encephalopathy (2) . A second episode occurred within a year in 17 patients but the longest interval was 25 years. Useful investigations were those used in adults: magnetic resonance imaging, visual evoked responses, and cerebrospinal fluid examination for IgG and oligoclonal bands.
On the whole the prognosis for children seemed somewhat better than for adults. Fifteen patients were well after follow up for between three and over 30 years. Eight died from three to 43 years after the onset. Four patients had a steadily progressive course from the onset. Twenty one had a relapsing-remitting course all along and two developed a progressive illness after a period of relapsing-remitting. One was lost to follow up.
One child aged 13 months at onset had a progressive course and died aged 9 and another aged 2 years at onset had a relapsing-remitting course and was well at the age of 15 years (G F Cole and colleagues, Developmental Medicine and Child Neurology 1995; 37: 667-72).
Multiple sclerosis may occur at any age past infancy and paediatricians should be prepared to consider the diagnosis, perhaps before the classical 'dissemination of lesions in space and time' has occurred.
